Robert J Scaringe

CEO Robert J Scaringe sells 34,818 RIVN shares at $15.00 via pre-arranged 10b5-1 plan; stock at $16.30, CEO retains 922,286 shares

Robert J Scaringe sold 34,818 shares (34.8K shares) at $15.00 on 2026-05-28 under a pre-arranged 10b5-1 trading plan adopted on 2025-03-14, meaning this transaction was scheduled rather than discretionary. The sale reduced his holdings by 3.6% to 922,286 shares (922.3K shares) post-transaction. Rivian trades at $16.30 currently, 28.2% below its 52-week high of $22.69, with the company unprofitable over its most recent full fiscal year despite $1.4B quarterly revenue. His prior five trades at RIVN show a mixed pattern: four of the five prior sales posted negative 30-day and 90-day returns, with the most recent sale on 2026-02-18 followed by 30-day -11.2% and 90-day -23.2% declines, though the 2025-04-07 sale marked an exception with 90-day +16.2% gains. Given the pre-arranged nature of this transaction, no timing inference is warranted; however, the broader context of negative equity near a 52-week low and the company's unprofitability warrants tracking stock performance in the 30 and 90 days ahead.

Rivian CEO Robert Scaringe sold 34,900 shares at $16.80 under pre-arranged 10b5-1 plan; retains 1,044,731 shares post-sale

Scaringe executed a scheduled sale of 34,900 shares (34.9K shares) for $586,236.24 ($586.2K) on 2026-02-18 under a 10b5-1 trading plan adopted on 2025-03-14. The transaction reduced his holdings by 3.2% from 1,079,631 shares (1.08M shares) to 1,044,731 shares (1.04M shares). Since the sale was pre-arranged rather than discretionary, it reflects a predetermined schedule established roughly 11 months prior and does not signal a near-term change in the CEO's conviction regarding the company. The CEO retained substantial equity—over 1 million shares—consistent with material alignment of personal and shareholder interests.

CEO Scaringe sold 52,350 shares of RIVN at $16.60 on 2025-11-11 for $868,832.01; stock now down 9.0% from 52-week high.

Scaringe reduced his RIVN holdings by 52,350 shares (-4.0% vs pre-transaction holdings) at $16.60, maintaining a substantial position of 1,246,405 shares post-sale. The stock has appreciated 24.9% over the 30 days and 33.9% over the 90 days prior to this sale, but remains 9.0% below its 52-week high of $18.02. His prior RIVN trades show a mixed timing pattern: 2 of 5 prior same-ticker sells were well-timed (with negative 90d returns), while his cross-ticker track record shows a 52.94% well-timed rate with an average 90d return of -8.6% across 17 prior sells. The company remains unprofitable with net income of $-1,173,000,000.00 on revenue of $1,558,000,000.00 in the latest quarter, despite 12.1% annual revenue growth. This sale occurs against a backdrop of strong recent price appreciation but persistent fundamental losses.

RIVN CEO Scaringe sells 178,572 shares for $2.7M under pre-arranged 10b5-1 plan executed May 15–19

Robert J. Scaringe, CEO of Rivian Automotive, executed two separate sales totaling 178,572 shares for $2,731,022.94 at a blended average price of $15.29. His shareholding declined from 1,661,683 shares to 1,483,111 shares, a reduction of 10.7% of pre-transaction holdings. These transactions were conducted under a pre-arranged 10b5-1 trading plan adopted on 2024-03-08, meaning the sales were scheduled and not discretionary decisions. The scheduled nature of this plan removes timing discretion from the characterization, and the CEO retains substantial equity ownership at 1.48M shares post-sale.

CEO Robert J Scaringe sold 71,429 RIVN shares at $11.25 on 2025-04-07 via pre-arranged 10b5-1 plan

Robert J Scaringe, Chief Executive Officer of Rivian Automotive, sold 71,429 shares at $11.25 on 2025-04-07 as part of a pre-arranged 10b5-1 trading plan adopted on 2024-03-08. This is a scheduled, non-discretionary transaction executed under a predetermined plan, reducing his post-transaction holdings from 924,440 shares to 853,011 shares. The sale represents a -7.7% reduction in his pre-transaction holdings and is a routine execution of the established trading schedule rather than a discretionary market decision.

CEO Robert J. Scaringe sold 71,429 RIVN shares at $11.82 on 2025-03-24 via pre-arranged 10b5-1 plan

Robert J. Scaringe, Rivian's Chief Executive Officer, sold 71,429 shares at $11.82 on 2025-03-24 pursuant to a pre-arranged 10b5-1 trading plan adopted on 2024-03-08, reducing his holdings from 924,440 shares to 853,011 shares. The sale was scheduled, not discretionary, reflecting predetermined execution rather than a market-timing decision. As the company's CEO, the magnitude of Scaringe's remaining stake—853,011 shares—indicates substantial ongoing alignment with shareholder interests despite the reduction.

CEO Scaringe sells 71,429 RIVN shares at $11.25; stock now at $10.75, down 40.6% from 52-week high.

Scaringe sold 71,429 shares on 2025-03-12 at $11.25, reducing his holdings by 7.7% to 853,011 shares. The stock has since fallen to $10.75, down 13.9% over the past 30 days and 25.2% over 90 days, currently trading 40.6% below its 52-week high of $18.11. At the same-ticker level, Scaringe's prior five trades at RIVN show a 1-of-3 well-timed rate at the 90-day horizon, with mixed outcomes: his January 2025 sell preceded a 21.0% decline, while his November 2024 sell preceded a 25.0% gain. The company remains unprofitable with a net income of $-1.1B against quarterly revenue of $874.0M, though annual revenue growth stood at 12.1%. The sale occurs within a period of sustained stock weakness and follows a pattern of regular insider selling at this ticker, warranting monitoring of whether subsequent quarters show margin improvement or continued losses.

Rivian CEO Robert Scaringe sold 71,429 shares at $16.17 on 2025-01-06; stock now down 27.4% from 52-week high despite +38.5% rebound in past 90 days.

CEO Robert Scaringe sold 71,429 shares for $1,155,092.64, reducing holdings from 934,790 to 863,361 shares (net -7.6%). The sale price of $16.17 was 13.8% above the current price of $14.21 and within the 52-week range of $8.40–$19.58. At the same-ticker level, Scaringe has made 5 prior trades at RIVN with mixed outcomes: a recent sell on 2024-11-25 showed +25.0% in the following 30 days; earlier sells on 2024-09-23 and 2024-09-12 posted +18.9% and +0.6% at the 90-day mark, indicating his prior RIVN sells were not well-timed (stock rose after). The company remains unprofitable (net income $-1.1B), though revenue grew 167.4% year-over-year, and Scaringe has continued selling throughout late 2024. This transaction occurs in the context of substantial revenue growth but persistent losses and a stock that has recovered 38.5% in 90 days despite remaining 27.4% below its yearly high.

CEO Robert Scaringe sold 71,429 shares of RIVN at $13.88, reducing holdings by -7.6%; stock now +21.6% in 30 days post-sale

CEO Robert Scaringe sold 71,429 shares on 2024-12-23 at $13.88, reducing his RIVN position by -7.6% from 934,790 to 863,361 shares, generating $991,291.66 in proceeds. The stock has since rallied +21.6% over 30 days and +21.0% over 90 days, trading at $14.04 against a 52-week high of $23.73. His prior RIVN sales show a mixed track record: of five measurable same-ticker sales, only one (2024-09-23) was well-timed with a negative 90-day return of +18.9%; three others suffered 90-day declines ranging from -23.2% to -41.0%. Cross-ticker, his sell timing has been poor (50% well-timed rate across 10 prior sells with -14.4% average 90-day return). The company remains unprofitable with a $-1.1B net loss despite $874.0M quarterly revenue and strong +167.4% annual growth, creating fundamental uncertainty beneath recent price appreciation.

CEO Robert Scaringe sold 71,429 shares of RIVN at $13.65 on 2024-12-12 under pre-arranged 10b5-1 plan (975.2K proceeds)

Robert Scaringe, CEO of Rivian Automotive, sold 71,429 shares at $13.65 per share on 2024-12-12 for 975.2K in total value. This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2024-03-08, making it a scheduled disposition rather than a discretionary decision. Post-transaction holdings of 863,361 shares represent a 7.6% reduction from the prior balance of 934,790 shares. As a scheduled sale under a 10b5-1 plan, this transaction does not carry timing-based signal value and should be evaluated within the context of the plan's adoption parameters and the CEO's ongoing retention level.